LON:OXIG - Oxford Instruments plc (OXIG.L) Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: GBX 1,415.83
  • Forecasted Upside: -27.02 %
  • Number of Analysts: 7
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 6 Buy Ratings
  • 0 Strong Buy Ratings
GBX 1,940
▼ -10 (-0.51%)
1 month | 3 months | 12 months
Get New Oxford Instruments plc (OXIG.L) Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for OXIG and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for OXIG

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
GBX 1,415.83
▼ -27.02% Downside Potential
This price target is based on 7 analysts offering 12 month price targets for Oxford Instruments plc (OXIG.L) in the last 3 months. The average price target is GBX 1,415.83, with a high forecast of GBX 1,485 and a low forecast of GBX 1,360. The average price target represents a -27.02% upside from the last price of GBX 1,940.
Buy
The current consensus among 7 investment analysts is to buy stock in Oxford Instruments plc (OXIG.L). This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/25/2019
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/23/2019
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/21/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/20/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/19/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/17/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/16/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/15/2021

Latest Recommendations

  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetDetails
11/12/2020Shore CapitalReiterated RatingBuy
i
7/9/2020Berenberg BankBoost Price TargetBuyGBX 1,215 ➝ GBX 1,485
i
6/9/2020Peel HuntReiterated RatingBuyGBX 1,400
i
6/9/2020JPMorgan Chase & Co.Boost Price TargetOverweightGBX 1,250 ➝ GBX 1,450
i
6/9/2020Liberum CapitalBoost Price TargetBuyGBX 1,200 ➝ GBX 1,400
i
6/9/2020Peel HuntBoost Price TargetBuyGBX 1,200 ➝ GBX 1,400
i
6/9/2020Shore CapitalReiterated RatingBuy
i
6/1/2020Jefferies Financial GroupLower Price TargetHoldGBX 1,395 ➝ GBX 1,360
i
6/1/2020Peel HuntReiterated RatingBuy
i
5/15/2020Berenberg BankReiterated RatingBuy
i
4/24/2020Peel HuntReiterated RatingBuy
i
4/16/2020Jefferies Financial GroupLower Price TargetHoldGBX 1,530 ➝ GBX 1,395
i
3/30/2020Shore CapitalReiterated RatingBuy
i
3/30/2020Peel HuntReiterated RatingBuy
i
3/26/2020Berenberg BankLower Price TargetBuyGBX 1,825 ➝ GBX 1,215
i
3/23/2020JPMorgan Chase & Co.Lower Price TargetOverweightGBX 1,462 ➝ GBX 1,250
i
3/18/2020Shore CapitalReiterated RatingBuy
i
3/18/2020Peel HuntReiterated RatingBuy
i
2/24/2020Berenberg BankReiterated RatingBuyGBX 1,825
i
2/24/2020Shore CapitalReiterated RatingBuy
i
2/19/2020Peel HuntBoost Price TargetBuyGBX 1,450 ➝ GBX 1,850
i
1/29/2020Peel HuntReiterated RatingBuy
i
1/29/2020Shore CapitalReiterated RatingBuy
i
1/17/2020Berenberg BankReiterated RatingBuyGBX 1,825
i
11/29/2019Berenberg BankUpgradeBuyGBX 1,400 ➝ GBX 1,825
i
11/27/2019Jefferies Financial GroupBoost Price TargetHoldGBX 1,070 ➝ GBX 1,530
i
11/13/2019JPMorgan Chase & Co.Boost Price TargetOverweightGBX 1,180 ➝ GBX 1,462
i
11/12/2019Peel HuntReiterated RatingBuyGBX 1,450
i
11/12/2019Peel HuntReiterated RatingBuyGBX 1,450
i
11/12/2019Shore CapitalReiterated RatingBuy
i
10/23/2019Shore CapitalReiterated RatingBuy
i
9/10/2019Shore CapitalReiterated RatingBuy
i
9/9/2019Peel HuntReiterated RatingBuyGBX 1,300 ➝ GBX 1,450
i
6/19/2019Berenberg BankLower Price TargetBuyGBX 1,400 ➝ GBX 1,040
i
6/13/2019Numis SecuritiesReiterated RatingBuyGBX 1,460
i
6/11/2019JPMorgan Chase & Co.Boost Price TargetOverweightGBX 1,025 ➝ GBX 1,180
i
6/11/2019Peel HuntBoost Price TargetBuyGBX 1,100 ➝ GBX 1,300
i
6/6/2019Numis SecuritiesReiterated RatingBuy
i
6/3/2019Peel HuntReiterated RatingBuy
i
2/11/2019Peel HuntLower Price TargetBuyGBX 1,200 ➝ GBX 1,100
i
12/4/2018JPMorgan Chase & Co.Lower Price TargetOverweightGBX 1,180 ➝ GBX 1,025
i
11/14/2018JPMorgan Chase & Co.Reiterated RatingOverweight
i
11/13/2018Peel HuntReiterated RatingBuy
i
9/11/2018Peel HuntReiterated RatingBuy
i
9/11/2018Liberum CapitalReiterated RatingBuy
i
9/5/2018Jefferies Financial GroupReiterated RatingHold
i
8/3/2018Liberum CapitalReiterated RatingBuy
i
8/3/2018Peel HuntReiterated RatingBuy
i
7/20/2018Peel HuntBoost Price TargetBuyGBX 1,070 ➝ GBX 1,200
i
7/13/2018Liberum CapitalReiterated RatingBuyGBX 1,100
i
7/2/2018Liberum CapitalReiterated RatingBuy
i
6/14/2018Berenberg BankUpgradeBuy
i
6/13/2018Numis SecuritiesReiterated RatingBuy
i
6/13/2018JPMorgan Chase & Co.Boost Price TargetOverweightGBX 1,100 ➝ GBX 1,180
i
6/12/2018Shore CapitalReiterated RatingHold
i
6/12/2018Peel HuntBoost Price TargetBuyGBX 1,020 ➝ GBX 1,070
i
6/8/2018Liberum CapitalReiterated RatingBuy
i
4/12/2018JPMorgan Chase & Co.Reiterated RatingOverweight
i
4/11/2018Liberum CapitalReiterated RatingBuyGBX 1,100
i
4/11/2018Shore CapitalReiterated RatingHoldGBX 795
i
4/9/2018Peel HuntReiterated RatingBuyGBX 1,020
i
3/23/2018Liberum CapitalReiterated RatingBuy
i
3/6/2018Liberum CapitalReiterated RatingBuyGBX 1,100
i
2/27/2018Peel HuntReiterated RatingHoldGBX 1,020
i
2/22/2018Jefferies Financial GroupUpgradeHoldGBX 850 ➝ GBX 845
i
2/13/2018JPMorgan Chase & Co.Lower Price TargetOverweightGBX 1,180 ➝ GBX 1,030
i
1/12/2018Liberum CapitalUpgradeBuyGBX 1,100
i
12/18/2017BarclaysLower Price TargetOverweightGBX 1,145 ➝ GBX 1,090
i
12/5/2017Numis SecuritiesReiterated RatingBuyGBX 1,275
i
11/30/2017Berenberg BankBoost Price TargetHoldGBX 700 ➝ GBX 1,050
i
11/15/2017JPMorgan Chase & Co.Reiterated RatingOverweightGBX 1,180
i
11/14/2017Peel HuntReiterated RatingHoldGBX 1,020
i
11/14/2017Liberum CapitalReiterated RatingHoldGBX 1,150
i
11/13/2017Shore CapitalReiterated RatingHold
i
10/31/2017Peel HuntReiterated RatingHoldGBX 1,020
i
9/26/2017Jefferies Financial GroupBoost Price TargetUnderperformGBX 575 ➝ GBX 850
i
9/13/2017JPMorgan Chase & Co.Reiterated RatingOverweightGBX 1,180
i
9/12/2017Peel HuntReiterated RatingHoldGBX 1,020
i
9/12/2017Shore CapitalReiterated RatingHold
i
9/6/2017Berenberg BankReiterated RatingHold
i
8/17/2017BarclaysReiterated RatingOverweightGBX 1,145
i
6/29/2017Shore CapitalReiterated RatingHold
i
6/21/2017JPMorgan Chase & Co.Reiterated RatingOverweightGBX 1,180
i
6/21/2017BarclaysBoost Price TargetOverweightGBX 1,070 ➝ GBX 1,145
i
6/14/2017Numis SecuritiesUpgradeBuyGBX 1,375
i
6/14/2017JPMorgan Chase & Co.Boost Price TargetOverweightGBX 1,075 ➝ GBX 1,180
i
6/13/2017Shore CapitalReiterated RatingHold
i
6/13/2017Liberum CapitalReiterated RatingHoldGBX 1,150
i
5/11/2017Liberum CapitalBoost Price TargetHoldGBX 690 ➝ GBX 1,150
i
5/10/2017JPMorgan Chase & Co.Boost Price TargetOverweightGBX 930 ➝ GBX 1,075
i
5/5/2017Peel HuntBoost Price TargetHoldGBX 800 ➝ GBX 950
i
4/27/2017Numis SecuritiesUpgradeBuyGBX 1,220
i
4/27/2017JPMorgan Chase & Co.Reiterated RatingOverweightGBX 930
i
4/26/2017N+1 SingerReiterated RatingHoldGBX 810
i
4/25/2017BarclaysReiterated RatingOverweight
i
4/13/2017Shore CapitalReiterated RatingHold
i
4/13/2017N+1 SingerReiterated RatingHoldGBX 810
i
4/13/2017Liberum CapitalReiterated RatingHold
i
4/5/2017Peel HuntBoost Price TargetHoldGBX 735 ➝ GBX 800
i
4/4/2017Stifel NicolausReiterated RatingBuy
i
3/27/2017BarclaysReiterated RatingOverweightGBX 1,070
i
3/21/2017BarclaysReiterated RatingOverweight
i
2/9/2017Berenberg BankReiterated RatingHoldGBX 700
i
1/23/2017Stifel NicolausReiterated RatingBuy
i
1/16/2017BarclaysBoost Price TargetOverweightGBX 970 ➝ GBX 1,070
i
1/4/2017JPMorgan Chase & Co.Boost Price TargetOverweightGBX 890 ➝ GBX 930
i
12/12/2016BarclaysReiterated RatingOverweightGBX 970
i
11/22/2016JPMorgan Chase & Co.Reiterated RatingOverweight
i
11/18/2016N+1 SingerReiterated RatingHoldGBX 810
i
11/18/2016Shore CapitalReiterated RatingSell
i
11/16/2016Numis SecuritiesUpgradeAddGBX 815 ➝ GBX 750
i
11/16/2016BarclaysReiterated RatingOverweightGBX 970
i
11/16/2016Jefferies Financial GroupReiterated RatingUnderperformGBX 575
i
11/16/2016JPMorgan Chase & Co.Boost Price TargetOverweightGBX 870 ➝ GBX 890
i
9/14/2016Jefferies Financial GroupReiterated RatingOverweightGBX 870
i
9/14/2016Numis SecuritiesDowngradeHoldGBX 880 ➝ GBX 815
i
9/14/2016JPMorgan Chase & Co.Reiterated RatingOverweightGBX 870
i
9/13/2016Liberum CapitalReiterated RatingHoldGBX 690
i
8/22/2016JPMorgan Chase & Co.Reiterated RatingOverweightGBX 870
i
7/21/2016Beaufort SecuritiesDowngradeHold
i
7/11/2016BarclaysReiterated RatingOverweightGBX 840
i
6/17/2016Peel HuntBoost Price TargetHoldGBX 600 ➝ GBX 735
i
6/16/2016Beaufort SecuritiesUpgradeSpeculative Buy
i
6/16/2016JPMorgan Chase & Co.Reiterated RatingOverweightGBX 870
i
6/15/2016Liberum CapitalReiterated RatingHoldGBX 690
i
6/13/2016InvestecReiterated RatingHoldGBX 678
i
5/9/2016Shore CapitalReiterated RatingSell
i
4/19/2016Berenberg BankReiterated RatingHoldGBX 700
i
4/13/2016BarclaysReiterated RatingOverweightGBX 840
i
4/13/2016Numis SecuritiesLower Price TargetBuyGBX 950 ➝ GBX 880
i
4/13/2016JPMorgan Chase & Co.Reiterated RatingOverweightGBX 870
i
4/12/2016Shore CapitalReiterated RatingSell
i
4/12/2016InvestecReiterated RatingHoldGBX 678
i
4/4/2016BarclaysReiterated RatingOverweightGBX 840
i
3/11/2016Shore CapitalReiterated RatingSell
i
3/7/2016Beaufort SecuritiesReiterated RatingSpeculative Buy
i
2/12/2016JPMorgan Chase & Co.Reiterated RatingOverweightGBX 870
i
2/11/2016InvestecDowngradeSellGBX 620 ➝ GBX 605
i
2/1/2016Liberum CapitalReiterated RatingHoldGBX 690
i
1/26/2016Jefferies Financial GroupLower Price TargetUnderperformGBX 555 ➝ GBX 550
i
1/25/2016BarclaysReiterated RatingOverweightGBX 840
i
1/22/2016Peel HuntUpgradeHoldGBX 600
i
1/22/2016InvestecLower Price TargetHoldGBX 670 ➝ GBX 620
i
1/22/2016JPMorgan Chase & Co.Reiterated RatingOverweightGBX 870
i
1/22/2016Liberum CapitalReiterated RatingHoldGBX 690
i
(Data available from 1/15/2016 forward)
Oxford Instruments plc (OXIG.L) logo
Oxford Instruments plc, through its subsidiaries, researches, develops, manufactures, rents, sells, and services tools and systems in the United Kingdom, China, Japan, the United States, Germany, rest of Europe, rest of Asia, and internationally. It operates through Materials and Characterisation, Research and Discovery, and Service and Healthcare segments. The company offers atomic force microscopy products; tools for use in research and development across a range of applications, including semiconductors, renewable energy, mining, metallurgy, and forensics; etch and deposition processing equipment and solutions for use power and RF devices, VCSELs/lasers, 2D materials, augmented reality, biomems, failure analysis, HBLEDs, infrared sensors, MEMS and sensors, and quantum; and low temperature systems comprising wet systems, magnet systems, instrumentation products, and custom and specialty systems. It also provides optical imaging products; and nuclear magnetic resonance (NMR) instruments, including NMR spectrometers, QC/QA analyzers, and rock core analyzers for use in applications, such as agriculture and food, automotive and aviation, building and construction, chemicals, environment, illicit drugs testing, mining and minerals, pharma, polymers, rock core analysis, textiles, and education. In addition, the offers MRI and CT serving products; scientific cameras spectroscopy solutions, microscopy systems, and software for applications comprising astronomy, bio imaging and life science, energy generation and storage, forensics and environment, photonics, quantum technology, semiconductors, microelectronics, and data storage; and manufacture of x-ray tubes, power supplies, and integrated x-ray sources for analytical, medical imaging, food quality and packaging inspection, and industrial NDT markets. Oxford Instruments plc was founded in 1959 and is headquartered in Abingdon, the United Kingdom.
Read More

Today's Range

Now: GBX 1,940
1,910
2,020

50 Day Range

MA: GBX 1,966.98
1,840
2,098.15

52 Week Range

Now: GBX 1,940
724
2,175

Volume

29,386 shs

Average Volume

44,202 shs

Market Capitalization

£1.11 billion

P/E Ratio

31.70

Dividend Yield

0.21%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Oxford Instruments plc (OXIG.L)?

The following Wall Street sell-side analysts have issued stock ratings on Oxford Instruments plc (OXIG.L) in the last year: Berenberg Bank, Jefferies Financial Group Inc., JPMorgan Chase & Co., Liberum Capital, Peel Hunt, Peel Hunt LLP, and Shore Capital.

What is the current price target for Oxford Instruments plc (OXIG.L)?

6 Wall Street analysts have set twelve-month price targets for Oxford Instruments plc (OXIG.L) in the last year. Their average twelve-month price target is GBX 1,415.83, suggesting a possible downside of 27.0%. Berenberg Bank has the highest price target set, predicting OXIG will reach GBX 1,485 in the next twelve months. Jefferies Financial Group Inc. has the lowest price target set, forecasting a price of GBX 1,360 for Oxford Instruments plc (OXIG.L) in the next year.

What is the current consensus analyst rating for Oxford Instruments plc (OXIG.L)?

Oxford Instruments plc (OXIG.L) currently has 1 hold rating and 6 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe OXIG will outperform the market and that investors should add to their positions of Oxford Instruments plc (OXIG.L).

What other companies compete with Oxford Instruments plc (OXIG.L)?

How do I contact Oxford Instruments plc (OXIG.L)'s investor relations team?

Oxford Instruments plc (OXIG.L)'s physical mailing address is Tubney Woods, ABINGDON, OX13 5QX, United Kingdom. The company's listed phone number is +44-1865-393200. The official website for Oxford Instruments plc (OXIG.L) is www.oxford-instruments.com.